Navigation Links
Marrone Bio Innovations Named an IC20 Company
Date:11/18/2009

DAVIS, Calif., Nov. 18 /PRNewswire/ -- Marrone Bio Innovations (MBI), a leader in the discovery, development and commercialization of effective and environmentally responsible pest management products, announced that it has been named an IC20 company by the Investors' Circle, the United States' oldest and largest national angel investing group.

Companies named to the IC20 excel in performance leading to rewarding results for all stakeholders, including investors, the environment and society. Qualitative and quantitative metrics are used to assess 197 companies, identifying the top achievers in financial, social, and environmental success.

"MBI's selection as an IC20 company recognizes our commitment to bringing effective, natural, environmentally sound pest management products to the marketplace," states Pam Marrone, Founder and CEO of MBI. "Our success comes from solving our customers unmet needs, and providing safe, effective products to replace and augment disappearing synthetic alternatives. Our mission inherently benefits the environment, and our success rewards those who have contributed financially to our growth and achievements, such as the Investors' Circle."

Marrone Bio Innovations (MBI) discovers, develops and markets effective and environmentally responsible products that fill unmet needs for weed, disease and pest management. MBI's effective and safe products come from a combination of in-licensed technology and its own discovery. The company's own R&D finds naturally occurring microorganisms from unique habitats and develops them into pest management products. MBI has an impressive pipeline of new products, including two insecticides, two herbicides and Zequanox(TM), a product for controlling invasive zebra and quagga mussels in fresh waterways. MBI currently markets Regalia® for control of fungal and bacterial diseases of both food and ornamental crops, and GreenMatch® Burndown Herbicide for weed control in organic crop production.

Investors' Circle is a network of over 225 angel investors, professional venture capitalists, foundations, family offices and others who are using private capital to promote the transition to a sustainable economy. Since 1992, Investors' Circle has facilitated the flow of over $133 million into more than 200 companies and small funds addressing social and environmental issues.

SOURCE Marrone Bio Innovations


'/>"/>
SOURCE Marrone Bio Innovations
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Glycos Biotechnologies, Inc. Selected to Present at Alternative Energy Innovations 2009
2. Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET October 27, 2009 to Discuss Third Quarter 2009 Results
3. The Growing Demand for Organic Gardening Sprouts New Self Sustaining Innovations
4. Cambrex Continuous-Flow Microwave-Assisted Organic Synthesis Technology Nominated for 2009 Innovations Award
5. Morphotek(R), Inc. and Cancer Innovations, Inc. Announce Evaluation and Option Agreement for Therapeutic Monoclonal Antibodies
6. Inverness Medical Innovations - Concateno plc, Further Announcement Regarding UK Takeover Code Share Dealing Disclosure Requirements.
7. Exosome Diagnostics and DxS Diagnostic Innovations Collaborate to Develop Blood-Based Tests for Key Cancer Mutations
8. Carbon Design Innovations, Inc. Introduces Carbon Nanotube Probe Technology for Atomic Force Microscopy, CNT-Probes Deliver New Level of AFM Imaging Performance
9. Kibow Biotech, Inc. to Present at BIO 2009 International Convention: Innovations to Heal, Fuel, and Feed the World
10. Health Care Innovations and Opportunities Attract Attendees from 40 Countries and Delegations from 12 to 6th Annual World Health Care Congress
11. Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... On Thursday, March 23, 2017, ... down 0.07%; the Dow Jones Industrial Average edged 0.02% ... closed at 2,345.96, marginally dropping 0.11%. US markets saw ... 4 sectors finished in red, and 1 sector ended ... reports coverage on the following Biotechnology equities: BioDelivery Sciences ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... ... viscoelastic material that exhibits both viscous and elastic characteristics when deformed, which is ... polymer exhibits properties to gently absorb compressive forces and return to its natural ...
(Date:3/23/2017)... March 23, 2017  Northwest Biotherapeutics (OTCQB: NWBO) ... immune therapies for solid tumor cancers, today announced ... financing it announced last Friday, March 17, 2017. ... institutional investors securities totaling 28,843,692 shares, comprised of ... 10,000,000 shares of Class C Warrants pre-funded at ...
(Date:3/23/2017)... MENLO PARK, Calif., March 23, 2017  BioPharmX ... developing products for the dermatology market, today reported ... Jan. 31, 2017, and will provide an update ... from the year. "We are pleased ... productive year for BioPharmX," said President Anja Krammer. ...
Breaking Biology Technology:
(Date:3/2/2017)... -- Summary This report provides all the information ... and activities since 2010. ... Read the full report: http://www.reportlinker.com/p03605615-summary/view-report.html ... provides an in-depth insight into the partnering activity of one ... demand company reports are prepared upon purchase to ensure inclusion ...
(Date:3/2/2017)... Australian stem cell and regenerative medicine company, ... an agreement with the Monash Lung Biology Network, a ... and Department of Pharmacology at Monash University, ... to support the use of Cymerus™ mesenchymal stem cells ... Asthma is a chronic, long term lung condition recognised ...
(Date:2/28/2017)... , February 28, 2017 News solutions ... ... Amsterdam from 14 to 16 March, Materna will ... and show how seamless travel is a real benefit for passengers. ... added biometrics to their passenger touch point solutions to take passengers ...
Breaking Biology News(10 mins):